APA (7th ed.) Citation

Hochhaus, A., Erben, P., & Reiter, A. (2013). Effect of the tyrosine kinase inhibitor nilotinib in patients with hypereosinophilic syndrome/chronic eosinophilic leukemia: Analysis of the phase 2, open-label, single-arm A2101 study. Journal of cancer research and clinical oncology, 139(12), .

Chicago Style (17th ed.) Citation

Hochhaus, Andreas, Philipp Erben, and Andreas Reiter. "Effect of the Tyrosine Kinase Inhibitor Nilotinib in Patients with Hypereosinophilic Syndrome/chronic Eosinophilic Leukemia: Analysis of the Phase 2, Open-label, Single-arm A2101 Study." Journal of Cancer Research and Clinical Oncology 139, no. 12 (2013).

MLA (9th ed.) Citation

Hochhaus, Andreas, et al. "Effect of the Tyrosine Kinase Inhibitor Nilotinib in Patients with Hypereosinophilic Syndrome/chronic Eosinophilic Leukemia: Analysis of the Phase 2, Open-label, Single-arm A2101 Study." Journal of Cancer Research and Clinical Oncology, vol. 139, no. 12, 2013.